Description

1,32,827 equity shares of Dr.Agarwals Eye Hospital Ltd. issued on preferential basis to promoters listed and permitted for trading with effect from October 29, 2025.

Summary

BSE has announced the listing of 1,32,827 new equity shares of Dr.Agarwals Eye Hospital Ltd. (Scrip Code: 526783) issued to promoters on a preferential basis. These shares will be listed and permitted to trade on the exchange with effect from Wednesday, October 29, 2025. The shares were allotted at a premium of Rs. 5260/- per share and carry a lock-in period until April 29, 2027.

Key Points

  • Number of shares listed: 1,32,827 equity shares of Rs. 10/- each
  • Issue price: Rs. 5270.00/- (Rs. 10/- face value + Rs. 5260/- premium)
  • Allotment type: Preferential basis to promoters
  • Date of allotment: September 26, 2025
  • Trading start date: October 29, 2025
  • Distinctive numbers: 4700001 to 4832827
  • ISIN: INE934C01018
  • Ranking: Pari-passu with existing equity shares

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for new securities issued under existing regulations.

Compliance Requirements

  • Trading members must note the listing of these new securities in their systems
  • The shares are subject to lock-in restrictions and cannot be freely traded until the lock-in period expires
  • All 1,32,827 shares (distinctive numbers 4700001 to 4832827) are locked-in until April 29, 2027

Important Dates

  • Date of Allotment: September 26, 2025
  • Trading Commencement: October 29, 2025
  • Lock-in Expiry: April 29, 2027
  • Notice Date: October 28, 2025

Impact Assessment

Market Impact: Low. The preferential allotment to promoters represents a capital raising exercise with minimal immediate market impact. The shares are locked-in until April 2027, preventing any selling pressure on the stock price.

Liquidity Impact: Negligible in the short term due to the lock-in period. The 1,32,827 shares will only become tradable after April 29, 2027.

Corporate Impact: The Rs. 70.03 crore capital raised (1,32,827 shares × Rs. 5,270) strengthens the company’s equity base and may be used for business expansion or other corporate purposes.

Investor Considerations: Existing shareholders should note the dilution from the preferential allotment, though the lock-in period provides stability by preventing immediate promoter selling.

Impact Justification

Routine listing of preferential allotment to promoters with lock-in period; limited market impact due to restricted tradability until 2027